During the first 2 years of this project, the investigators have made a number of observations which support the hypothesis that substance P (SP) plays an important role in regulating mononuclear phagocyte function and affects HIV infection in vitro. They have demonstrated that human monocytes and lymphocytes express SP mRNA transcripts, including a novel isoform, and secrete SP protein. SP mRNA and protein are altered by HIV infection of these cells in vitro. The investigators propose to continue and extend the studies on the molecular mechanism(s) of SP modulation of HIV infection in human monocyte/macrophages (M/M) including brain microglia. They will study the mechanisms of interaction between SP and HIV, including the effects on NFkappaB binding to HIV promoter LTR, effects on HIV cycle replication, and effects on chemokine levels and chemokine receptor expression. The overarching hypothesis is that SP is affected by life stress, anxiety, and/or depression in HIV-infected patients and may be associated with progression of HIV infection, particularly CNS infection, by affecting immune cell functions. Circulating SP levels may increase as a result of HIV infection of M/M and/or the presence of acute or chronic life stress, anxiety and/or depression. Using peripheral blood samples from two adult cohorts of HIV+ and HIV- men and women, they will test the hypotheses that SP is up-regulated by HIV infection in vivo, SP is further up-regulated by degree of life stress, anxiety and/or depression; and SP is a risk predictor for cognitive changes and/or CNS manifestations of HIV infection. Using PBMS, the investigators will relate SP protein and mRNA levels in cells derived from these cohorts to measures of psychiatric, neurologic, endocrine, immunologic and virologic status. These studies will provide new information about the biological link between the CNS and the immune system and may delineate a new marker that can be used to detect risk of progression in patients with HIV and/or life stress and depression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH049981-07
Application #
6392035
Study Section
Neuro-Immunology, Virology, and AIDS Review Committee (NIVA)
Program Officer
Joseph, Jeymohan
Project Start
1995-07-01
Project End
2003-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
7
Fiscal Year
2001
Total Cost
$422,899
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Douglas, Steven D (2016) Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches. Br J Haematol 175:187-188
Barrett, Jeffrey S; Spitsin, Sergei; Moorthy, Ganesh et al. (2016) Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV. J Transl Med 14:148
McGuire, Jennifer L; Gill, Alexander J; Douglas, Steven D et al. (2015) Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neurovirol 21:439-48
Tebas, Pablo; Spitsin, Sergei; Barrett, Jeffrey S et al. (2015) Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults. AIDS 29:931-9
McGuire, Jennifer L; Kempen, John H; Localio, Russell et al. (2015) Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth. Clin Vaccine Immunol 22:27-36
McGuire, Jennifer L; Barrett, Jeffrey S; Vezina, Heather E et al. (2014) Adjuvant therapies for HIV-associated neurocognitive disorders. Ann Clin Transl Neurol 1:938-52
Tuluc, Florin; Meshki, John; Spitsin, Sergei et al. (2014) HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P. J Leukoc Biol 96:143-50
Schwartz, Lynnae; Spitsin, Sergei V; Meshki, John et al. (2013) Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor. J Neurovirol 19:219-27
Spitsin, Sergei; Tuluc, Florin; Meshki, John et al. (2013) Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor. Neuroimmunomodulation 20:247-55
Spitsin, Sergei; Stevens, Kathleen E; Douglas, Steven D (2013) Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology. J Neurol Sci 334:18-23

Showing the most recent 10 out of 33 publications